Botulinum Toxin Market Overview, Trends, Size by 2031
肉毒杆菌毒素市场规模预计将从 2023 年的 73.8 亿美元增长到 2031 年的 190.3 亿美元,2023-2031 年复合年增长率为 12.6%。该报告包括当前肉毒杆菌毒素市场趋势带来的增长前景及其在预测期内的可预见影响。
肉毒杆菌毒素是 由名为肉毒梭菌的细菌产生的神经毒素。将毒素注射到肌肉后,它会阻断肌肉的神经信号,从而阻止肌肉收缩,减少面部不想要的线条或特征。肉毒杆菌毒素注射剂(如 Botox 和Dysport)通过放松引起皱纹的肌肉来改善外观。这些注射剂还可以治疗偏头痛、多汗症、膀胱过度活动症和眼部问题。由于发展中国家提供的巨大增长机会,肉毒杆菌毒素市场规模很可能在 2031 年激增。
增长动力:
肉毒杆菌毒素用于改善面部美观的用途日益广泛,推动了肉毒杆菌毒素市场的发展
整容手术和注射肉毒杆菌毒素是最受欢迎的非侵入性美容手术之一。根据ISAPS 的数据,2020 年,肉毒杆菌毒素治疗是全球领先的非侵入性美容手术。此外,还会进行基于 A 型肉毒杆菌毒素 ( BoNTA ) 的面部美容治疗以改善上脸和下脸部的美观。在过去十年中,面部美容手术比不同类型的传统手术更受欢迎。根据 ISAPS 的数据,2020年全球进行了约 730 万例肉毒杆菌毒素手术。此外,2020 年美国共进行了 250 万例涉及肉毒杆菌毒素的微创美容手术。因此,所有年龄段的男性和女性面部美容手术中肉毒杆菌毒素的采用激增,正在推动肉毒杆菌毒素市场的增长。
2021 年非手术治疗(按国家/地区划分)
非手术治疗 | 全世界 | 我们 | 巴西 | 日本 | 墨西哥 | 意大利 | 德国 | 火鸡 | 阿根廷 | 印度 | 希腊 |
肉毒杆菌毒素 | 7,312,616 | 2,520,000 | 542,520 | 458,749 | 266,928 | 129,720 | 306,296 | 229,346 | 158,900 | 99,384 | 76,626 |
资料来源:国际美容整形外科学会 ( ISAPS ),2021 年
尽管肉毒杆菌毒素治疗已在世界范围内获得批准,可用于治疗眼睑和喉咙痉挛、减少面部皱纹和控制过度出汗,但这种毒素可能会引起严重的副作用,甚至危及生命。肉毒杆菌毒素治疗的常见副作用如下所述。
- 由于相关肌肉无力,患者在说话、吞咽或呼吸方面会遇到困难。这些副作用可能很严重,甚至会导致死亡。
- 肉毒杆菌毒素扩散到注射部位以外的身体部位会导致严重症状。这些不良影响包括肌力丧失和肌肉无力、视力模糊、复视、眼睑下垂、说话不清楚、声音嘶哑或变声或失声、失去膀胱控制、吞咽困难和呼吸困难。
- 肉毒杆菌毒素的其他副作用包括上呼吸道感染。接受肉毒杆菌治疗尿失禁的儿童可能会出现 尿路感染和尿液细菌。接受尿失禁治疗的成年人除了尿路感染外,其他副作用还包括排尿疼痛。
肉毒杆菌毒素带有黑框警告。黑框警告是美国食品药品监督管理局 (FDA) 就药物可能产生的有害副作用发出的官方警告。肉毒杆菌毒素扩散到注射部位外可能会导致与肉毒中毒相同的症状。此外,头痛或流感样症状、歪斜的笑容和干眼症是肉毒杆菌毒素的其他主要副作用。这些有害的副作用限制了肉毒杆菌毒素治疗的采用,从而阻碍了肉毒杆菌毒素市场的增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
肉毒杆菌毒素市场:
复合年增长率(2023 - 2031)12.6%- 2023 年市场规模
73.8 亿美元 - 2031年市场规模
190.3亿美元
市场动态
- 非侵入性美容手术日益流行
- 越来越多地使用肉毒杆菌毒素来改善面部美观
- 扩大治疗应用
- 新兴经济体中美容整形的采用率不断上升
关键人物;主力;重要一员
- AbbVie Inc.,
- 梅尔茨制药公司,
- Medytox,
- 益普生制药,
- 高德美,
- Revance Therapeutics Inc.,
- 兰州生物制品研究所有限公司
- Evolus 公司,
- Hugel 公司,
- 阿夸维特
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 肉毒杆菌毒素 A
- 肉毒杆菌毒素 B
- 医疗的
- 审美的
- 专科及皮肤科诊所
- 医院和诊所
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
报告细分和范围:
肉毒杆菌毒素市场分析通过考虑以下几个部分来进行:产品、应用和最终用户。
节段分析:
按产品划分,肉毒杆菌毒素市场分为肉毒杆菌毒素 A 和肉毒杆菌毒素 B。肉毒杆菌毒素 A 部分在 2023 年占据了较大的肉毒杆菌毒素市场份额。预计在 2023-2031 年期间,其复合年增长率将达到 12.7%。A 型肉毒杆菌毒素是一种纯化形式,具有广泛的应用和良好的安全性。它用于阻断乙酰胆碱的释放,用于治疗慢性流涎、痉挛和肌张力障碍,以及用于各种化妆品应用。
根据应用,肉毒杆菌毒素市场分为医疗和美容两大类。医疗领域在 2023 年占据了更大的市场份额,预计在 2023-2031 年期间的复合年增长率将达到 13.3%。医疗领域的市场进一步分为慢性偏头痛、肌肉痉挛、膀胱过度反应、多汗症等。此外,美容领域的市场细分为皱眉纹/眉间纹、额头纹、鱼尾纹、方下颌/咬肌等。肉毒杆菌毒素是一种神经毒素,用于治疗和控制各种疾病,包括慢性偏头痛、痉挛性疾病、颈部肌张力障碍和逼尿肌过度活跃。肉毒杆菌毒素的医疗应用包括慢性偏头痛、肌肉痉挛、膀胱过度反应和多汗症。
按照最终用户划分,肉毒杆菌毒素市场分为专科和皮肤科诊所、医院和诊所以及其他。专科和皮肤科诊所部分在 2023 年占据最大的市场份额。预计在预测期内,其复合年增长率最高,为 13.4%。
区域分析:
肉毒杆菌毒素市场报告的范围包括北美、欧洲、亚太地区、中东和非洲以及南美和中美洲。2023 年,北美占据了最大的肉毒杆菌毒素市场份额。该地区市场的增长是由上述国家进行的非手术或微创美容手术数量的增加推动的。用肉毒杆菌毒素注射减少面部皱纹是美国最常进行的美容手术。对于愿意将美容治疗纳入其实践的临床医生来说,这是最常见的入门级手术之一。根据国际美容整形外科协会 (ISAPS) 的数据,2021 年美国进行了近 250 万例肉毒杆菌毒素手术。通过 FDA 批准的用于美容适应症和水平额头皱纹的肉毒杆菌毒素治疗方法治疗皱眉纹和鱼尾纹可提供可预测的结果,同时表现出更少的副作用和高患者满意度。该国市面上出售的肉毒杆菌毒素产品包括 Allergan 的 BOTOX Cosmetic/Vistabel、Galderma 和 Ipsen 的 Dysport/Azzalure、Merz 的 Xeomin/Bocouture 以及 Evolus 的 Jeuveau(仅由 Daewoong 在美国生产)。美国 FDA 已批准 BOTOX Cosmetic 供 18-65 岁年龄段的人使用。
欧洲在全球肉毒杆菌毒素市场中占有重要地位,预计在预测期内将录得强劲增长率。该地区的市场增长主要归因于肉毒杆菌毒素公司的产品开发,以及德国、英国、法国和意大利等欧洲国家各年龄段人群对现代美容标准的认识不断提高。此外,医疗保健系统的进步可能会在未来几年推动该地区对肉毒杆菌毒素的需求。
肉毒杆菌毒素市场报告范围
报告属性 | 细节 |
---|---|
2023 年的市场规模 | 73.8亿美元 |
2031 年市场规模 | 190.3亿美元 |
全球复合年增长率(2023 - 2031) | 12.6% |
历史数据 | 2021-2022 |
预测期 | 2024-2031 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
竞争格局和重点公司:
肉毒杆菌毒素市场预测可以帮助该市场的利益相关者规划其增长战略。AbbVie Inc.、Merz Pharma、Medytox、Ipsen Pharma、Galderma、Revance Therapeutics Inc.、兰州生物制品研究所有限公司、Evolus Inc、Hugel Inc 和 Aquavit 是肉毒杆菌毒素市场报告中介绍的知名公司。这些公司专注于开发新技术、升级现有产品并扩大其地理覆盖范围,以满足全球不断增长的消费者需求。根据公司新闻稿,以下是一些最新进展:
- 2024 年 1 月,Medytox, Inc. 宣布成立 Luvantas, Inc. 作为其全资北美子公司。Luvantas 是一家新的医疗美容公司,致力于为北美市场提供创新解决方案。该公司正在与 Medytox 合作,寻求批准其即将推出的 NivobotulinumtoxinA 将其引入美国和加拿大。
- 2024年3月,医美公司Hugel获得美国FDA批准,可使用Letybo注射剂(letibotulinumtoxinA-wlbg)治疗眉间纹。
- 2022年10月,Hugel向美国FDA重新提交了其肉毒杆菌毒素Botulax的生物制品许可申请(BLA),用于治疗眉间纹。Hugel在提交Botulax(50和100单位)的BLA以进入美国市场后,于2022年3月收到了美国FDA的完整回复函(CRL)。该公司根据CRL中提出的要求提交了补充文件和数据,并向美国FDA重新提交了BLA。获得批准后,Hugel于2023年上半年进入美国市场。
- 2022 年 2 月,Merz Therapeutics 投资高达 300 万美元,扩大与以色列 Vensica Therapeutics 的战略合作伙伴关系。此次投资是在 2021 年签署战略许可和合作协议之后进行的。Merz 由此履行了合同协议,参与 Vensica 的 C 轮融资并投资这家初创公司。
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The botulinum toxin market, based on product, is bifurcated into botulinum toxin A and botulinum toxin B. The botulinum toxin A segment held a larger market share in 2023, and it is anticipated to register a higher CAGR during 2023–2031.
US holds the largest market share in botulinum toxin market. Facial wrinkle reduction with botulinum toxin injections is the most performed cosmetic procedure in the US. It is one of the most common entry-level procedures for clinicians willing to incorporate aesthetic treatments into their practice. According to the ISAPS, nearly 2.5 million botulinum toxin procedures were performed in the US in 2021. BOTOX Cosmetic/Vistabel by Allergan, Dysport/Azzalure by Galderma and Ipsen, Xeomin/Bocouture by Merz, and Jeuveau by Evolus (manufactured only by Daewoong for the US) are among the commercially available botulinum toxin products in the country. The US FDA has approved BOTOX Cosmetic for people from the age group of 18–65.
The botulinum toxin market by end user, is categorized into specialty and dermatology clinics, hospitals and clinics, and others. The specialty and dermatology clinics segment held the largest market share in 2023.
The botulinum toxin market by application is bifurcated into medical and aesthetic. The medical segment held the largest botulinum toxin market share in 2023 and is anticipated to register the highest CAGR of 13.3% during 2023–2031.
The botulinum toxin market majorly consists of the players such as AbbVie Inc., Merz Pharma, Medytox, Ipsen Pharma, Galderma, Revance Therapeutics Inc., Lanzhou Institute of Biological Products Co Ltd, Evolus Inc, Hugel Inc, and Aquavit.
Botulinum toxins are neurotoxins produced by bacteria named Clostridium botulinum. After the toxin is injected into a muscle, it blocks nerve signals to the muscle, thereby blocking its contraction and resulting in a reduction in unwanted facial lines or features. Botulinum toxin injections such as Botox and Dysport improve the appearance by relaxing the muscles that cause wrinkles. These injections also treat migraines, hyperhidrosis, overactive bladder, and eye problems..
The factors that are driving growth of the market are the rising popularity of non-invasive aesthetics procedures and increasing use of botulinum toxin for enhancing facial aesthetics.
The List of Companies - Botulinum Toxin Market
- F. Hoffmann-La Roche Ltd
- Becton Dickinson and Co
- ARKRAY Inc
- Sysmex Partec GmbH
- Fujirebio Europe NV
- bioMerieux SA
- Cepheid
- Meril Life Sciences Pvt Ltd
- QIAGEN NV
- OraSure Technologies Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.